A World Health Organization panel has advised against the use of antiviral drug remdesivir for patients hospitalised with Covid-19 - no matter how ill they are.
Currently, there is no evidence that it improves patient survival or need for ventilation, the panel says.
We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can
trust. For only R75 per month, you have access to
a world of in-depth analyses, investigative journalism,
top opinions and a range of features. Journalism
strengthens democracy. Invest in the future today.
